Test Price
2,800 AEDโ Home Collection Available
CTRC Gene Pancreatitis Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Sequencing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Complimentary Post-Test Telephonic Consultation for Result Interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
This NGS-based assay provides comprehensive analysis of the CTRC gene coding region to identify pathogenic variants linked to hereditary pancreatitis, delivering 99.9% diagnostic sensitivity and enabling early risk stratification and personalized surveillance planning.
Test Overview & Methodology
The CTRC Gene Pancreatitis Genetic Test utilizes Next-Generation Sequencing (NGS) to comprehensively analyze the entire coding region of the CTRC gene, identifying pathogenic variants responsible for hereditary pancreatitis. This test empowers individuals and clinicians to assess lifetime pancreatitis risk, enabling personalized surveillance and early intervention strategies.
| Feature | Our CTRC NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Detection Precision | โฅ99.9% sensitivity for point mutations, indels | ~95โ98%, limited to targeted exons |
| Methodology | Next-Generation Sequencing (NGS) | Sanger sequencing (manual, exon-by-exon) |
| Turnaround Time | 3โ4 weeks | 6โ8 weeks (fragmented workflow) |
| Coverage | Full gene analysis (coding + splice sites) | Limited to pre-selected regions |
Pre-Test Requirements
Clinical history documentation, including a three-generation family pedigree. A mandatory genetic counselling session will be arranged to map affected relatives and discuss test implications. Fasting is not required; sample options include a single blood draw, extracted DNA, or a dried blood spot on an FTA card.
Physician Insight & Safety Protocols
โGenetic testing for hereditary pancreatitis provides powerful predictive information, but it must be paired with expert counselling and a complete clinical picture. A negative result does not eliminate all genetic or environmental contributors, and ongoing collaboration with your gastroenterologist remains essential for comprehensive care.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Important Medication Advisory
Do not discontinue any prescribed medication without consulting your doctor. Genetic test results do not alter acute treatment requirements. Always follow your physicianโs guidance for current medications.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Not for acute pancreatitis emergency diagnosis; not validated for fetal screening; testing of minors requires legal guardian consent under UAE Federal Decree-Law No. 4 of 2016 on Medical Liability; results must be reviewed by a healthcare professional alongside genetic counselling.
- Emergency Red Flags: Sudden, severe upper abdominal pain radiating to the back; persistent vomiting; fever >38.5ยฐC; jaundice; confusion or signs of shock โ seek emergency care immediately.
Patient FAQ & Clinical Guidance
1. What exactly does the CTRC gene pancreatitis test look for?
This Next-Generation Sequencing test pinpoints disease-causing CTRC gene mutations that significantly elevate hereditary pancreatitis risk. It analyzes the entire coding sequence of CTRC to identify known pathogenic variants as well as novel mutations associated with pancreatitis susceptibility. The report categorises findings into pathogenic, likely pathogenic, or variants of uncertain significance, ensuring you receive actionable information alongside genetic counselling.
2. How long does it take to get results and what will they tell me?
The comprehensive NGS analysis delivers a detailed genetic report within 3 to 4 weeks, revealing your CTRC mutation status and associated pancreatitis risk. Your personalised report will indicate whether a mutation was detected, its clinical significance, and specific, evidence-based recommendations for screening and family testing. A post-test tele-consultation ensures you correctly interpret the findings and discuss next steps.
3. Can I use this test if I have no symptoms but a family history?
Absolutely, this predictive genetic test accurately identifies inherited CTRC mutations before symptom onset, empowering proactive health planning for at-risk individuals. Even without personal history of pancreatitis, a positive result guides lifestyle modifications, regular imaging surveillance, and early specialist referral. The test is also invaluable for clarifying inheritance patterns in families affected by recurrent pancreatitis.
4. What sample types are accepted for this genetic test?
The test accepts peripheral whole blood collected via standard venipuncture, extracted DNA samples, or dried blood spots on FTA cards. VIP Mobile Phlebotomy is available daily from 8 AM to 11 PM for home collection, with temperature-controlled cold-chain transport to the laboratory.
5. Will my insurance cover the CTRC gene pancreatitis test?
Coverage varies by insurance provider and policy. We offer direct billing verification via WhatsApp at +971 54 548 8731. Our team will assist with pre-authorization and claims submission to maximize your reimbursement.
UAE Regulatory & Data Privacy Adherence
This diagnostic service operates under DHA Facility License Number 1143 and complies fully with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, access-controlled, and processed solely for diagnostic purposes. Patient consent is obtained in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring informed decision-making and safe clinical practice.
Clinical & Logistical Metadata
| Test Name | CTRC Gene Pancreatitis Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 weeks |
| Sample Type / Matrix | Peripheral whole blood, extracted DNA, or dried blood spot (FTA card) |
| Methodology Used | Next-Generation Sequencing (NGS) โ Full gene coding region + splice sites |
| ICD-10-CM Code | K86.1 |
| LOINC Code | 21656-6 |
| DHA Facility License & Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians